Alnylam Pharmaceuticals
ALNY
#788
Rank
S$39.86 B
Marketcap
S$297.92
Share price
3.63%
Change (1 day)
-50.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company